Oralcept is a non-steroidal anti-inflammatory drug (NSAID).
Release form and composition
Dosage form Oralsept - spray for local use dosed 0,255 mg / dose, which is a clear solution of yellow-green color with the aroma of peppermint. Available in 30 ml (176 doses) in a plastic, white, opaque container with a dispenser and a folding tip, each container together with the instructions for use is placed in a cardboard box.
The composition of one dose of the drug:
- Active ingredient: benzydamine hydrochloride - 0.255 mg;
- Excipients: methyl parahydroxybenzoate - 0.17 mg, ethanol 96% - 17.00 mg, glycerin (glycerol) - 8.50 mg, peppermint flavoring 27198/14 - 0.17 mg, sodium saccharinate - 0.0408 mg, polysorbate -60 - 0.0085 mg, sodium bicarbonate - 0.0034 mg, quinoline yellow dye 70 (E 104) - 0.0034 mg, indigotin dye 85% (E 132) - 0.00017 mg, purified water up to 170 μl.
Indications for use
Symptomatic therapy of pain syndrome of inflammatory diseases of the oral cavity and ENT organs (of various etiologies):
- Pharyngitis, laryngitis, tonsillitis;
- Gingivitis, glossitis, periodontal disease, stomatitis (including after radiation and chemotherapy);
- Calculous inflammation of the salivary glands;
- After treatment or removal of teeth;
- After surgery and injuries (tonsillectomy, fractures of the jaw);
- Candidiasis of the oral mucosa (in combination therapy).
In infectious and inflammatory diseases requiring systemic treatment, Oralcept is used as part of a combination therapy.
- Children's age up to 3 years;
- Hypersensitivity to benzydamine or other components of the drug.
Use with caution in the following cases:
- Hypersensitivity to acetylsalicylic acid or other nonsteroidal anti-inflammatory drugs;
- Bronchial asthma (including in history).
There are not enough data from animal studies on the effects during pregnancy and during breastfeeding, and adequate and well-controlled studies in pregnant women have not been done, and it is not known whether benzydamine enters breast milk, therefore, there is no potential risk for humans. defined
During pregnancy and during breastfeeding, Oralsept is used only after consulting with a doctor in the event that the intended benefits to the mother outweigh the potential risk to the fetus and child.
Dosing and Administration
Oralcept applied topically.
One dose of spray corresponds to 1 click. One dose corresponds to one breath and is equivalent to 0.17 ml of solution.
- Adults and children over 12 years: 4-8 doses 2-6 times a day;
- Children aged 3-6 years: 1 dose per 4 kg of body weight (maximum - 4 doses) 2-6 times a day;
- Children aged 6-12 years: 4 doses 2-6 times a day.
A course of treatment:
- In inflammatory diseases of the oral cavity and pharynx: from 4 to 15 days;
- For odonto-dental pathology: from 6 to 25 days;
- After surgery and injuries (tonsillectomy, fractures of the jaw): from 4 to 7 days.
When using the drug for a long time, consultation with a doctor is necessary.
Directions for use:
- Holding the bottle vertically, lift the cap nozzle at a 90 ° angle to the bottle.
- Insert the nozzle into the oral cavity and press the cap several times according to the recommended dose. The period between two presses must be at least 5 seconds.
- Return the nozzle to its original position.
Warning: before first use, press the sprayer several times into the air.
Do not exceed the recommended dosage. Before use, consult your doctor.
- Local reactions: dry mouth, numbness, burning sensation in the mouth;
- Allergic reactions: hypersensitivity reactions, including skin rash, pruritus, urticaria, photosensitivity, angioedema, anaphylactic reactions;
- Other: laryngospasm.
If any of these side effects are exacerbated, or any other adverse reactions that are not listed in the instructions, should be reported to the doctor.
To date, no cases of overdose of Oralsept have been reported. However, it is known that benzydamine in case of accidental ingestion in a high dose (hundreds of times higher than therapeutic), especially in children, can cause agitation, convulsions, tremor, sweating, ataxia and vomiting. Such an acute overdose requires immediate gastric lavage, restoration of water and electrolyte balance, symptomatic treatment, adequate hydration.
In the case of receiving a dose that exceeds the recommended, you should rinse your mouth with a sufficient amount of water, in case of adverse reactions - contact your doctor.
Not studied. Not established pharmaceutical incompatibility Oralsepta with other drugs.
With the use of Oralcept, hypersensitivity reactions may develop. In this case, it is recommended to discontinue treatment and consult a physician to prescribe appropriate therapy.
If there is an ulcer lesion of the mucous membrane of the oropharynx, the patient should consult a doctor if symptoms persist for more than three days.
The use of the drug is not recommended for patients with hypersensitivity to acetylsalicylic acid or other nonsteroidal anti-inflammatory drugs.
Oralcept should be used with caution in patients with bronchial asthma, as in this case the development of bronchospasm is possible.
Avoid spraying the eyes. In case of contact with eyes, rinse with plenty of water.
The drug does not affect the ability to drive a car, perform potentially hazardous activities that require increased concentration of attention and psychomotor reactions, or to another type of activity that requires increased attention.
Terms and conditions of storage
Store at a temperature not exceeding 25 ° C in the reach of children.
Shelf life - 4 years.